General
Preferred name
IRIGENIN
Synonyms
Irigenin ()
P&D ID
PD002204
CAS
548-76-5
Tags
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Irigenin is a is a lead compound, and mediates its anti-metastatic effect by specifically and selectively blocking ¦Á9¦Â1 and ¦Á4¦Â1 integrins binding sites on C-C loop of Extra Domain A (EDA). Irigenin shows anti-cancer properties. It sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells[1].
PRICE 50
DESCRIPTION Irigenin mediates its antimetastatic effect by specifically and selectively blocking the ??9??1 and ??4??1 integrin binding sites on the C-C loop of the Extra Domain A domain. It can sensitize TRAIL-induced apoptosis by enhancing the expression of pro-apoptotic molecules in gastric cancer cells and has anti-cancer effects.
DESCRIPTION Irigenin mediates its antimetastatic effect by specifically and selectively blocking the α9β1 and α4β1 integrin binding sites on the C-C loop of the Extra Domain A domain. It can sensitize TRAIL-induced apoptosis by enhancing the expression of pro-apoptotic molecules in gastric cancer cells and has anti-cancer effects. (TargetMol Bioactive Compound Library)
Compound Sets
5
Cayman Chemical Bioactives
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
External IDs
30
Properties
(calculated by RDKit )
Molecular Weight
360.08
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
3
Rotatable Bonds
4
Ring Count
3
Aromatic Ring Count
3
cLogP
2.6
TPSA
118.59
Fraction CSP3
0.17
Chiral centers
0.0
Largest ring
6.0
QED
0.65
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Integrin
NF-κB
NF-¦ÊB
Apoptosis
MOA
NF-¦ÊB inhibitor
Pathway
NF-¦ªb
cytoskeleton
Cytoskeletal Signaling
Source data